Buy & Sell CureVac BV (CVAC) – CureVac BV Price Today
Key Stats
- $1.05BMarket Cap
- HealthSector
- -3M Drawdown
- $599.28MEnterprise Value
- -Dividend Yield
- 25 daysTypical Hold Time
CureVac BV (CVAC) is currently valued at a market capitalization of $1.05B, with an enterprise value of $599.28M. Over the past 52 weeks, CureVac BV has traded between a low of $2.59 and a high of $5.6, highlighting its annual price range. On average, investors hold CureVac BV for approximately 25 days, indicating typical investor behavior on the platform.
About CureVac BV
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-generation COVID-19 vaccine. CureVac's first attempt to develop a COVID-19 vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The company's other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases.
Most Recent News
Canada's new digital regulations risk stifling innovation and driving tech firms to the US, warns Yanik Guillemette.
Yanik Guillemette, a Canadian tech entrepreneur, criticizes Ottawa's increasing digital regulations, including a proposed 15% revenue tax on streaming platforms and laws C-11, C-18, and C-22. He argues these measures burden the tech ecosystem, raise ...
Canadian digital regulations risk driving tech innovation and investment out of the country, warns expert.
Yanik Guillemette, a Montreal-based entrepreneur and investment strategist, criticizes Canada's growing digital regulations, including the CRTC's proposal for streaming platforms to fund Canadian content. He argues these rules increase costs for cons...
Trump says Iran nuclear talks are progressing orderly, urges patience and keeps naval blockade until deal is done.
President Donald Trump stated that negotiations with Iran over its nuclear program are proceeding in an orderly and constructive manner. He emphasized the need for patience and warned against rushing the deal, maintaining the U.S. naval blockade on I...